Skip to main content
. 2004 Apr;24(8):3238–3250. doi: 10.1128/MCB.24.8.3238-3250.2004

TABLE 1.

Analysis of putative C/EBPβ target genesa

Gene Description KO/WTb
MCSFR CSF receptor 0.96
GMCSFR-α CSF 2 receptor α (low affinity) 0.62
IL-1Rγ IL-1 receptor, γ chain 0.93
TGF-β TGF β-1 0.75
IGF-I Insulin-like growth factor I 0.17
TNFSF13B B-cell activating factor 3.11
BAK BCL2 homologous antagonist 0.56
Bax-a BCL2-associated X protein 0.76
Bag-1 BCL2-associated athanogene 1 1.00
A1 B cell leukemia/lymphoma 2-related protein 3.86
MCL-1 Myeloid cell leukemia sequence 1 1.36
Cyt C Cytochrome c 1.07
RBP1 RBP I isoform III 1.14
RP105 Lymphocyte antigen 78 1.36
PAK P21-activated kinase 1 2.14
MDM-2 Mouse 3T3 cell double minute 2 0.60
TRP53 Transformation-related p53 0.86
CBP CREB binding protein 1.40
DP1 Transcription factor DP1 0.37
CDC2 Cell division cycle 2 homologue A 1.10
ODC Ornithine decarboxylase 1.11
Apex/Ref-1 Apurinic/apyrimidinic endonuclease 1.01
Ctsd Cathepsin D 1.20
a

Total RNA from J2-WT1 and J2-KO1 cell lines was used to prepare radiolabeled cDNA probes that were hybridized to a mouse apoptosis-survival gene array (R&D Systems). The hybridization signals were quantitated by phosphorimaging and normalized to GAPDH.

b

Normalized values from J2-KO1 cells were divided by J2-WT1 values to calculate relative expression in the two cell lines (KO/WT). This experiment was performed twice with similar results. Note that IGF-I expression decreased nearly sixfold in J2-KO1 cells.